1. Murata H., Adachi Y., Ebitsuka T., Chino Y., Takahashi R., Hayashi T., Goto D., Matsumoto I., Tsutsumi A., Akaza H., and Sumida T.:
Reiter's syndrome following intravesical Bacille bilie de Calmette-Guerin treatment for superficial bladder carcinoma. Report of six cases Mod. Rheumatol. 14:82-86,2004

2.Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., Goto D., Matsumoto I.,Murata H., Noguchi E., and Sumida T.:
Polymorphisms of IL-1β Gene in Japanese Patients with Sjogren’s Syndrome and Systemic Lupus Erythematosus.
J. Rheumatol.31:720-725,2004(3.151)

3.Muraki Y., Matsumoto I., Chino Y., Hayashi T., Suzuki E., Goto D., Ito S., Murata H., Tsutsumi A., Sumida T.:
Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies.Possible mechanism of autoantibody production
Biochem. Biophys. Research. Commun.323(2):518-522,2004(2.749)

4. Ota M., Mizukami K., Hayashi T., Sumida T., Asada T.:
Brain magnetic resonance imaging and single photon emission computerized tomography findings in a case of relapsing polychondritis showing cognitive impairment and personality changes.
Prog Neuropsychopharmacol Bio Psychiatry.29(2):347-349,2005(2.802)

5.Suzuki T., Muraki Y., Yasukochi T., Hua Zhang., Kori Y., Wakamatsu E., Hayashi T., Goto D., Ito S., Tsutsumi A., Sumichika H., Sumida T., Matsumoto I.:
Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys
Autoimmunity Reviews 4:475-478,2005(3.862)

6.Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
Clinical Characteristics of Anti-Glucose-6-Phosphate Isomerase Antibodies positive Japanese Patients with Rheumatoid Arthritis
Modern Rheumatoloogy 15:258-263,2005

7.Matsumoto I, Muraki Y, Yasukochi T, Hua Zhang, Kori Y, Hayashi T, Goto D, Ito S, Tsutsumi A, Ikeda K, Sumichika H, Sumida T.:
The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis
Int. J. Mol. Med .16(5):793-800,2005 (1.847)

8.Matsumoto I, Hua Zhang, Muraki Y, Hayashi T, Yasukochi T, Kori Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
A functional variant of Fcy receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-phosphate isomerase antibodies-positive individuals
Arthritis. Res. Ther. 7:1183-1188,2005(4.035)

9.Miyahara S, Ito S, Soeda A, Chino Y, Hayashi T, Takahashi R, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Two cases of systemic lupus erythematosus complicated with colonic ulcers.
Intern Med.44(12)1298-1306,2005

10.Kori Y., Matsumoto I., Hua Zhang., Yasukochi T., Hayashi T., Iwanami K., Goto D., Ito S., Tsutsumi A., Sumida T.:
Characterization of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis
Ann. Rheum. Dis.65:968-969,2006(6.411)

11.Suzuki E, Hayashi T, Ito S, Miyazaki K, Yamazaki H, Machino T, Takahashi R, Chino Y, Goto D, Matsumoto I, Tsutsumi A, Sato Y, Sumida T.:
A Case of Pulmonary Hypertension Associated with Systemic Lupus Erythematosus without Anti-ribonucleoprotein Antibodies.
ACTA MEDICA et BIOLOGICIA 53(3)87-93,2005

12.Tsutsumi A, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Significnace of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other phospholipids antibody assays.
Mod.Rheumatol.16:158-164,2006

13.Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.:
Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Arthritis Rheum 56(7):2160-2169,2007(7.677)

14.Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Sumida T.
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.
Intern Med 46:1033-1037, 2007

15.Hayashi T, Matsumoto I, Yasukochi T, Mamura M, Goto D, Ito S, Tsutsumi A, Sumida T.:
Biased usage of synovial immunoglobulin heavy chain variable region 4 by the anti-glucose-6-phosphate isomerase antibody in patients with rheumatoid arthritis.
Int. J. Mol. Med.20(2):247-253,2007(1.847)

16.Wang Y, Ito S, Chino Y, Iwanami K, Yasukochi T, Goto D, Matsumoto I, Hayashi T, Uchida K, Sumida T.:
Use of Laser Microdissection in the Analysis of Renal-infiltrating T cells in MRL/lpr Mice
Mod. Rheumatol 18:385-393,2008

17.Suzuki T, Tsutsumi A, Suzuki E, Sugihara M, Muraki Y, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Tristetraprolin(TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals
Mod. Rheumatol 18:472-479,2008

18. Ito I, Kawasaki A, Ito S, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Geoffrey Hom, Robert R. Graham, Takasaki Y, Hashimoto H, Ohashi J, Timothy W. Behrens, Sumida T, Tsuchiya N.:
Replication of the Association between C8orf13-BLK Region and Systemic Lupus Erythematosus in a Japanese Population.
Arthritis Rheum. 60(2):553-558,2009(7.677)

19.Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, Matsumoto I, Ito S, Tsutsumi A, Koga M, Arinami T, Robert R Graham, Geoffrey Hom, Takasaki Y, Hashimoto H, Timothy W Behrens, Sumida T, Tsuchiya N.:
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of STAT1-STAT4 region.
Arthritis Res Ther. 10:R113,2008(4.035)

20.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234,2009

21.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A new low-field extremity magnetic resonance imaging and proposed compact MRI score- Evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis.
Mod Rheumatol 19:358-365,2009

22.Wakamatsu E, Matsumoto I, Yoshiga Y, Hayashi T, Goto D, Ito S, Sumida T.:
Altered peptide ligands regulate type II collagen-induced arthritis in mice
Mod Rheumatol 19:366-371,2009

23.Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with Aortitis.
Intern. Med 48:1093-1097,2009

24.Segawa S, Goto D, Yoshiga Y, Hayashi T, Matsumoto I, Ito S, Sumida T.:
Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis.
Int. J. Mol. Med.24(4):481-486,2009

25.Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, Murata H, Tsutsumi A, Hayashi T, Uchida K, Usui J, Yamagata K,Sumida T.:
Laser Microdissection-based Analysis of Cytokine Balance in the Kidneys of Patients with Lupus Nephritis
Clin. Exp. Immunol. 159(1):1-10,2010

26. Ito I, Kawasaki A, Ito S, Kondo Y, Sugihara M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Takasaki Y, Hashimoto H, Matsuta K, Sumida T, Tsuchiya N.:
Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
Ann. Rheum. Dis.69:936-937,2010

27.Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.:
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis Res Ther.11:R167,Epub2009 Nov 9

28.Umeda N, Ito S, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment.
Intern. Med.49:187-189,2010

29.Segawa S, Goto D, Yoshiga Y, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Inhibition of transforming growth factor-b signaling attenuates IL-18 plus IL-2-induced interstitial lung disease in mice.
Clin. Exp. Immunol.160:394-402,2010

30.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Sugihara M, Horikoshi M, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
New low-field extremity MRI, compacTscan: comparison with whole body 1.5 tesla conventional MRI.
Mod. Rheumatol. 20(4):331-336,2010

31. Kawasaki A, Ito I, Ito S, Hayashi T, Goto D, Matsumoto I, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population.
Journal of Biomedicine and Biotechnology. Epub 2010 May 27

32.Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.:
New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren’s syndrome.
Clin. Exp. Immunol.162:53-61, 2010

33. Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T.:
Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis.
Modern Rheumatology 20:548-555,2010

34.Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.:
Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis.
J.Autoimmunity 35:383-389,2010

35.Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T, Ogishima H, Hayashi T, Goto D, Ito S, Matsumoto I, Sumida T.:
Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptpsis of human salivary gland cells.
Int J Rheum Dis. 14:86-91,2011

36.Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, Matsumoto I, Kusaoi M, Ohashi J, Graham R R, Matsuta K, Behrens T W, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population : a case-control association study.
Arthritis Res. Ther.12:R174,2010

37.Hikami K, Kawasaki A, Ito I, Koga M, Ito S, Hayashi T, Matsumoto I, Tsutsumi A, Kusaoi M, Takasaki Y, Hashimoto H, Arinami T, Sumida T, Tsuchiya N.:
Association of a functional polymorphism in the 3' untranslated region of SPI1 with systemic lupus erythematosus.
Arthritis Rheum. 63:755-763,2011

38.Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Tanaka Y, Umeda N, Hayashi T, Goto D, Ito S, Sekiguchi K, Sumida T.:
Comparative suppressive effect in models of autoimmune arthritis by tyrosine kinase inhibitors imatinib and nilotinib.
Mod. Rheumatol 21:267-275,2011

39.Segawa S, Goto D, Yoshiga Y, Horikoshi M, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Involvement of NK 1.1-Positive {gamma}{delta}T Cells in Interleukin-18 Plus Interleukin-2-Induced Interstitial Lung Disease.
Am. J. Res. Cell. Mol. Biol. 45(3):659-666,2011

40.Yoshiga Y, Goto D, Segawa S, Horikoshi M, Hayashi T, Matsumoto I, Ito S, Taniguchi S, Sumida T.:
Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Clin. Exp. Immunol. 164(2):236-247,2011

41.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Toll-like receptor 7(TLR7) SNPs in the 3' untranslated region and intron additively contribute to susceptibility to systemic lupus erythematosus in a Japanese female population.
Arthritis Res. Ther. 13(2):R41,2011

42.Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J, Kyogoku C, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Cumulative Association of Eight Susceptibility Genes with Systemic Lupus Erythematosus in a Japanese Female Population.
Journal of Human Genetics 56:503-507,2011

43.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, Kanamori A, Ochiai N, Miyazawa K, Sugihara M, Hayashi T, Goto D, Ito S, Sumida T.:
Six-transmembrane epithelial antigen of prostate4(STEAP4) is TNFalpha-induced protein that regulates IL-6, Il-8, and cell proliferation in synovium from patients with rheumatoid arthritis
Mod. Rheumatol 22:128-136, 2012

44.Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, Sugihara M, Hayashi T, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
Overexpression of T-bet gene regulates murine autoimmune arthritis
Arthritis Rheum.64(1):162-172,2012

45.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Umeda N, Tanaka Y, Sugihara M, Hayashi T, Ito S, Sumida T:.
Six-transmembrane epithelial antigen of prostate4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol.30(1):99-102,2012

46.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
Lupus 21(8):890-5.2012

47.Yamaguchi T, Ito S, Takano Y, Umeda N, Goto M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A case of a disseminated sporotrichosis patient treated with prednisolone, immunosuppressants, and tocilizumab under the diagnosis of rheumatoid arthritis.
Intern. Med.51(15):2035-9,2012

48.Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T.:
Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor inhibitors: One year follow-up by low-field extremity MRI.
Mod. Rheumatol 23(4):782-7,2013

49.Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tanaka Y, Tsuboi H, Suzuki T, Hayashi T, Ito S, Tsuchiya N, Sumida T.:
Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Clin. Exp. Immunol 172(1):44-53,2013

50.Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T.:
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Mod Rheumatol 21(1):52-59,2014

51.Furukawa H, Kawasaki A, Oka S, Shimada K, Masui T, Ikenaka T, Hashimoto A, Okazaki Y, Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A, Chiba N, Suematsu E, Fukui N, Hashomoto H, Sumida T, Ono M, Tsuchiya N, Tohma S:
Association of a Single Nucleotide Polymorphism in the SH2D1A Intronic Region with Systemic Lupus Erythematosus.
Lupus 22(5):497-503,2013

52.Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Amano H, Nagai T, Hirohara S, Setoguchi K, Kono Hm Okamoto A, Chiba N, Suematsu E, Katayama M, Migita K, Suda A, Ohno S, Hashimoto H, Takasaki Y, Sumida T, Nagaoka S, Tsuchiya N, Tohma S.:
Human Leukocyte Antigens and Systemic Lupus Erythematosus: A Protective Role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
PLoS One 9(2):e87792,2014